Project Grant HT9425261E444
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco a $1.7 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. The grant supports investigator-initiated biomedical research to develop PVRL2 (Poliovirus Receptor-Like 2) as a therapeutic target and biomarker for prostate cancer immunotherapy. This three-year effort aligns with the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco (UCSF) a $1,999,190 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2026, through September 29, 2030. This award supports UCSF's participation as a clinical research site within the Prostate Cancer Clinical Trials Consortium, a multi-institutional initiative focused on advancing prostate cancer research...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with a completion date of September 29, 2029. The award supports research to validate CD46 as a promising biomarker in advanced prostate cancer, aligning with the DHA's mission to transform healthcare for service members and the...
- This $1,211,127 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports a research project by the University of California, San Francisco (UCSF) to investigate the importance of immune responses to prostate tumor antigens primed by a combination of radiation and immunotherapy. The 4-year project aims to advance understanding of how to leverage the body's immune system to improve treatments for prostate cancer. As...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco (UCSF) a $1,054,812 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2026, through August 14, 2030. The project, titled "Biochemical and Structural Targeting of the GAQ-Mutant Melanoma Subtype," focuses on biomedical research addressing melanoma treatment through investigation of a specific...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,226,730 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award funds research investigating the canonical Polycomb Repressive Complex 1 (cPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This hypothesis-driven research initiative...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $878,043 to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2026, for a four-year project period concluding August 14, 2030. The project, "Biochemical and Structural Targeting of the GAQ-Mutant Melanoma Subtype," supports basic and applied biomedical research addressing Service Member health through...
- The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco a $1.148 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with completion scheduled for August 31, 2028. This three-year award funds research focused on targeting and imaging vitamin B5 metabolism in diffuse midline gliomas, a pediatric brain cancer with limited treatment options. The project...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...